Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 2 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

pembrolizumab 29 Carboplatin 15 Cisplatin 13 Nivolumab 12 atezolizumab 10 Radiotherapy 10 Paclitaxel 10 Ipilimumab 10 venetoclax 9 Pemetrexed 9 Docetaxel 9 durvalumab 8 Gemcitabine 8 fludarabine 7 Specimen Handling 7 Cyclophosphamide 7 Bevacizumab 7 tislelizumab 6 fludarabine phosphate 6 Trastuzumab 6 Practice Guidelines as Topic 6 Cetuximab 6 Biopsy 6 enzalutamide 5 Surveys and Questionnaires 5 Standard of Care 5 Radiosurgery 5 Magnetic Resonance Spectroscopy 5 Dexamethasone 5 Cytarabine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Omeprazole × 90 days × Clear all

NCT04930991 2026-06-01

OU202005AJ

University of Oklahoma

Phase EARLY_PHASE1 Terminated

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡